Invention Grant
US08653260B2 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
有权
羟甲基吡咯烷作为β3肾上腺素能受体激动剂
- Patent Title: Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
- Patent Title (中): 羟甲基吡咯烷作为β3肾上腺素能受体激动剂
-
Application No.: US13527934Application Date: 2012-06-20
-
Publication No.: US08653260B2Publication Date: 2014-02-18
- Inventor: Richard Berger , Lehua Chang , Scott D. Edmondson , Stephen D. Goble , Sookhee Nicole Ha , Nam Fung Kar , Ihor E. Kopka , Bing Li , Gregori J. Morriello , Chris R. Moyes , Ding-Ming Shen , Liping Wang , Cheng Zhu
- Applicant: Richard Berger , Lehua Chang , Scott D. Edmondson , Stephen D. Goble , Sookhee Nicole Ha , Nam Fung Kar , Ihor E. Kopka , Bing Li , Gregori J. Morriello , Chris R. Moyes , Ding-Ming Shen , Liping Wang , Cheng Zhu
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Patricia A. Shatynski; Valerie J. Camara
- Main IPC: C07D253/08
- IPC: C07D253/08 ; C07D487/04 ; C07D495/04 ; C07D239/80 ; C07D241/12 ; C07D265/06 ; C07D237/14 ; C07D237/16 ; C07D237/32 ; A61P13/06
Abstract:
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Public/Granted literature
- US20120258963A1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS Public/Granted day:2012-10-11
Information query
